CARLSBAD, Calif.--(BUSINESS WIRE)--Sep. 15, 2009-- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at the UBS Global Life Sciences Conference on September 22 at 8:30 a.m. Eastern Time at the Grand Hyatt Hotel in New York City. Greg Lucier, Life Technologies’ Chairman and Chief Executive Officer, will be presenting on behalf of the company. A live webcast of the presentation will be available on the investor relations page of the company’s website at ir.lifetechnologies.com. A replay of the webcast will be available for three weeks following the conference.
About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference, please visit our website: www.lifetechnologies.com.
Source: Life Technologies Corporation
Life Technologies CorporationAmanda ClardyVice President, Investor Relations760-476-7075ir@lifetech.com